Sergey Mikhailovich Ivanov - Institute of Biomedical Chemistry, Pirogov Russian National Research Medical University

基本信息

Career Trajectory

Bio

Sergey Mikhailovich Ivanov currently works at the Department for Bioinformatics, Institute of Biomedical Chemistry, Moscow. Sergey does research in Bioinformatics. His most recent publication is 'Network-Based Analysis of OMICs Data to Understand the HIV–Host Interaction.'

Research Interests

Papers共 61 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

DIGEP-Pred 2.0: A Web Application for Predicting Drug-Induced Cell Signaling and Gene Expression Changes

Sergey M. Ivanov,Anastasia V. Rudik,Alexey A. Lagunin,Dmitry A. Filimonov,Vladimir V. Poroikov

MOLECULAR INFORMATICS (2024)

Cited0Views0WOSBibtex

Identification of Proteins and Genes Associated with Hedgehog Signaling Pathway Involved in Neoplasm Formation Using Text-Mining Approach

Nadezhda Yu. Biziukova,Sergey M. Ivanov,Olga A. Tarasova

BIG DATA MINING AND ANALYTICSno. 1 (2024): 107-130

Cited0Views0EIBibtex

Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches

Olga Tarasova,Anthi Petrou,Sergey M Ivanov,Athina Geronikaki,Vladimir Poroikov

International journal of molecular sciencesno. 17 (2024)

Cited0Views0WOSBibtex

Transcriptome-based Analysis of Human Peripheral Blood Reveals Regulators of Immune Response in Different Viral Infections

Sergey M. Ivanov,Olga A. Tarasova,Vladimir V. Poroikov

Frontiers in Immunology (2023)

Cited0Views0WOSBibtex

Computational methods in the analysis of viral-host interactions

O. Tarasova,Sergey Ivanov,Nadezhda Biziukova, Shuanat Sh. Kabieva,Vladimir Poroikov

Elsevier eBookspp.285-302, (2023)

Cited0Views0Bibtex

On the Possibilities of Mining Waste Utilization in the Murmansk Region

S. Ivanov

Proceedings of the Komi Science Centre of the Ural Division of the Russian Academy of Sciencesno. 3 (2023): 79-85

Cited0Views0Bibtex

Подходы к репозиционированию лекарств для терапии COVID-19: in silico, in vitro, in vivo и в клинике

Vladimir Poroikov,Д. С. Дружиловский,Н.Ю. Бизюкова,А. В. Веселовский,Tatyana A. Gloriozova, О. А. Гомазков, А. В. Дмитриев,А. С. Иванов,Sergey Ivanov,Н. С. Ионов,Dmitry Karasev, А. С. Колодницкий,Alexey Lagunin,Pavel V. Pogodin,Anastasia V. Rudik,P I Savosina,Boris N. Sobolev,Л. А. Столбов, В. С. Сухачев, Р. Р. Такташев, А. В. Таланова,O. Tarasova,Д. А. Филимонов

Eksperimental'naia i klinicheskaia farmakologiiano. 11s (2023): 126-126

Cited0Views0Bibtex

Prediction of Adverse Effects of Drug–Drug Interactions on Cardiovascular System Based on the Analysis of Structure–Activity Relationships

Vladislav S. Sukhachev,Sergey M. Ivanov,Alexander V. Dmitriev

Biochemistryno. 5 (2023): 630-639

Cited0Views0WOSBibtex

CLC-Pred 2.0: A Freely Available Web Application for in Silico Prediction of Human Cell Line Cytotoxicity and Molecular Mechanisms of Action for Druglike Compounds

Alexey A. Lagunin,Anastasia V. Rudik,Pavel V. Pogodin,Polina I. Savosina,Olga A. Tarasova,Alexander V. Dmitriev,Sergey M. Ivanov,Nadezhda Y. Biziukova,Dmitry S. Druzhilovskiy,Dmitry A. Filimonov,Vladimir V. Poroikov

International journal of molecular sciencesno. 2 (2023): 1689-1689

Cited6Views0WOSBibtex

In Silico Estimation of the Safety of Pharmacologically Active Substances Using Machine Learning Methods: A Review

V. V. Poroikov, A. V. Dmitriev,D. S. Druzhilovskiy,S. M. Ivanov,A. A. Lagunin,P. V. Pogodin,A. V. Rudik,P. I. Savosina,O. A. Tarasova,D. A. Filimonov

Безопасность и риск фармакотерапииno. 4 (2023): 372-389

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn